The Continuing Battle for Universal Pharmacare with Marc-André Gagnon
Bill C-64 promises to bring pharmacare to Canadians, but gaps within the legislation may prevent it from fulfilling true universal pharmacare for all.
Bill C-64 promises to bring pharmacare to Canadians, but gaps within the legislation may prevent it from fulfilling true universal pharmacare for all.
After years of change and advancement in healthcare for Canadian citizens, Bill C-64 still might fall short of adequately and fairly providing pharmacare in Canada.
NDP members voted to withdraw support for the Liberal Confidence and Supply Agreement in Parliament if Pharmacare is not implemented. After the vote, what’s next?
When thinking about mental health care, one would expect medication coverage to be included. While mental health and pharmacare are parts of universal health care for many countries, Canada lags behind as the exception.
Inequity is a scourge on society, independent of absolute living conditions. It is the cause and consequence of differences in power and resources throughout society, not only at the lowest socioeconomic rungs.
Canada has long suffered from a broken pricing regime for prescription drugs. Now is the time for a new regime, one that supports the scientific community, encourages economic development and job creation.
It’s time we stopped being prisoners of foolish economic orthodoxies. A publicly-owned pharmaceutical company always made sense – and does so now more than ever.
As the federal government thinks about how to fill the holes in our social safety net that the pandemic has revealed, the creation of universal Pharmacare should be top of the priority list.
The growing call for universal drug coverage stems from the realization that Canadians should be able to take medications as prescribed, regardless of their financial situation.